<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">Heart disease</z:e> is the major cause of <z:hpo ids='HP_0011420'>death</z:hpo> in <z:mp ids='MP_0002055'>diabetes</z:mp>, a disorder characterized by <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and cardiovascular complications </plain></SENT>
<SENT sid="1" pm="."><plain>Although altered systemic regulation of <z:chebi fb="4" ids="27081">transition metals</z:chebi> in <z:mp ids='MP_0002055'>diabetes</z:mp> has been the subject of previous investigation, it is not known whether changed transition metal metabolism results in <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> in common forms of <z:mp ids='MP_0002055'>diabetes</z:mp> and whether metal chelation can reverse the condition </plain></SENT>
<SENT sid="2" pm="."><plain>We found that administration of the Cu-selective transition metal <z:chebi fb="0" ids="38161">chelator</z:chebi> trientine to rats with <z:chebi fb="1" ids="9288">streptozotocin</z:chebi>-induced <z:mp ids='MP_0002055'>diabetes</z:mp> caused increased urinary Cu excretion compared with matched controls </plain></SENT>
<SENT sid="3" pm="."><plain>A Cu(II)-trientine complex was demonstrated in the urine of treated rats </plain></SENT>
<SENT sid="4" pm="."><plain>In diabetic animals with established <z:hpo ids='HP_0001635'>heart failure</z:hpo>, we show here for the first time that 7 weeks of oral trientine therapy significantly alleviated <z:hpo ids='HP_0001635'>heart failure</z:hpo> without lowering blood <z:chebi fb="105" ids="17234">glucose</z:chebi>, substantially improved cardiomyocyte structure, and reversed elevations in left ventricular collagen and beta(1) integrin </plain></SENT>
<SENT sid="5" pm="."><plain>Oral trientine treatment also caused elevated Cu excretion in humans with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, in whom 6 months of treatment caused elevated left ventricular mass to decline significantly toward <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>These data implicate accumulation of elevated loosely bound Cu in the mechanism of cardiac damage in <z:mp ids='MP_0002055'>diabetes</z:mp> and support the use of selective Cu chelation in the treatment of this condition </plain></SENT>
</text></document>